Last reviewed · How we verify
NCT05552820
Electroacupuncture for Mild-to-moderate Dry Eye
NA trial testing Verum Electroacupuncture in Dry Eye in 168 participants. Currently enrolling.
31 December 2025
Quick facts
| Lead sponsor | Shanghai Institute of Acupuncture, Moxibustion and Meridian |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 168 |
| Start date | 12 October 2022 |
| Primary completion | 31 December 2025 |
| Estimated completion | 31 August 2026 |
| Sites | 1 location across China |
Drugs / interventions tested
- Verum Electroacupuncture
- Sham Electroacupuncture
Conditions studied
- Dry Eye — all drugs for Dry Eye →
Sponsor
Shanghai Institute of Acupuncture, Moxibustion and Meridian
Who can join
Adults 18 to 65, any sex, with Dry Eye. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To determine if electroacupuncture acts as an dry eye treatment rather than a placebo, and identify if benefits are linked to corneal subbasal nerve changes and neuroimmunomodulatory indicators.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Electroacupuncture for mild-to-moderate dry eye: study protocol for a multicentre, randomised, single-blind, sham-controlled trial.
Lu YQ, Yang G, Li MY, Hong J, et al · · 2023 · cited 3× · PMID 38056935 · DOI 10.1136/bmjopen-2022-069369
Verify or expand the search:
- PubMed search for NCT05552820
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Dry Eye
Currently open trials in the same condition.
- NCT07366944 — PCOS and Problem of Eye Dryness: Is There a Benefit From Lifetyle Changes · NA · recruiting
- NCT07329712 — Comparing Tear Proteomics Profile in Dry Eye Disease pre-and Post-treatment With Low Level Light Therapy · recruiting
- NCT07266948 — Impact of TRYPTYR on a Patient's Quality of Life and Ability to Perform Work · Phase 4 · recruiting
- NCT07298811 — Preliminary Clinical Study of the Effectiveness and Safety of Ocular Surface Microbiota Transplantation in the Treatment · Phase 1, PHASE2 · recruiting
- NCT07135193 — Evaluation of the Protective Effects of Cordyceps Cicadae on Visual Function and Anti-Fatigue Performance in Esports Ath · NA · active not recruiting
Other Shanghai Institute of Acupuncture, Moxibustion and Meridian trials
Trials by the same sponsor.
- NCT04980703 — Grain Moxibustion Treatment on Insomnia: a Randomized Controlled Trial · NA · not yet recruiting
- NCT07062133 — Effectiveness of Electrical Pudendal Nerve Stimulation for Neurogenic Lower Urinary Tract Dysfunction in Pediatric Tethe · NA · not yet recruiting
- NCT06553053 — Acupuncture Reduces Relapse in Patients With Crohn's Disease: a Superiority Trial · NA · recruiting
- NCT06158074 — Efficacy of Electrical Pudendal Nerve Stimulation and Sacral in Treating Non-obstructive Neurogenic Urinary Retention · NA · completed
- NCT06130306 — A PSM Analysis to Evaluate Electrical Pudendal Nerve Stimulation for PPI · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05552820 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Shanghai Institute of Acupuncture, Moxibustion and Meridian
- Last refreshed: 30 May 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05552820.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing